According to Benzinga Pro, during Q1, CRA International (NASDAQ:CRAI) earned $11.43 million, a 31.83% increase from the preceding quarter. CRA International also posted a total of $148.38 million in sales, a 10.1% increase since Q4.
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
According to Benzinga Pro, during Q4, CRA International (NASDAQ:CRAI) earned $8.67 million, a 20.81% increase from the preceding quarter. CRA International's sales decreased to $134.77 million, a 1.21% change since Q3.